Want to see BIOQ full AI Analyst Report?
Total Valuation
Bioqual has a market cap or net worth of $30.17M. The enterprise value is $53.17.
Market Cap$30.17M
Enterprise Value$53.17
Share Statistics
Bioqual has 893,838 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding893,838
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bioqual’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -2.93%.
Return on Equity (ROE)-0.03
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)-2.93%
Return on Capital Employed (ROCE)-0.04
Revenue Per Employee175.78K
Profits Per Employee-3.77K
Employee Count278
Asset Turnover0.86
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bioqual is ―. Bioqual’s PEG ratio is 0.12.
PE Ratio―
PS Ratio0.82
PB Ratio1.11
Price to Fair Value1.11
Price to FCF14.87
Price to Operating Cash Flow―
PEG Ratio0.12
Income Statement
In the last 12 months, Bioqual had revenue of 48.87M and earned -1.05M in profits. Earnings per share was -1.17.
Revenue48.87M
Gross Profit-1.90M
Operating Income-1.90M
Pretax Income-1.29M
Net Income-1.05M
EBITDA509.61K
Earnings Per Share (EPS)-1.17
Cash Flow
In the last 12 months, operating cash flow was 5.36M and capital expenditures -51.17K, giving a free cash flow of 5.31M billion.
Operating Cash Flow5.36M
Free Cash Flow5.31M
Free Cash Flow per Share5.94
Dividends & Yields
Bioqual pays an annual dividend of $0.5, resulting in a dividend yield of ―
Dividend Per Share$0.5
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.18
52-Week Price Change-23.47%
50-Day Moving Average33.91
200-Day Moving Average36.78
Relative Strength Index (RSI)43.19
Average Volume (3m)223.00
Important Dates
Bioqual upcoming earnings date is Sep 18, 2026, Before Open (Confirmed).
Last Earnings DateApr 21, 2026
Next Earnings DateSep 18, 2026
Ex-Dividend Date―
Financial Position
Bioqual as a current ratio of 3.72, with Debt / Equity ratio of ―
Current Ratio3.72
Quick Ratio3.72
Debt to Market Cap0.10
Net Debt to EBITDA-2.58
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Bioqual has paid -238.45K in taxes.
Income Tax-238.45K
Effective Tax Rate0.19
Enterprise Valuation
Bioqual EV to EBITDA ratio is 76.40, with an EV/FCF ratio of 14.39.
EV to Sales0.80
EV to EBITDA76.40
EV to Free Cash Flow14.39
EV to Operating Cash Flow13.22
Balance Sheet
Bioqual has $18.90M in cash and marketable securities with $33.48M in debt, giving a net cash position of $3.34M billion.
Cash & Marketable Securities$18.90M
Total Debt$33.48M
Net Cash$3.34M
Net Cash Per Share$3.74
Tangible Book Value Per Share$39.27
Margins
Gross margin is ―, with operating margin of -3.88%, and net profit margin of -2.14%.
Gross Margin―
Operating Margin-3.88%
Pretax Margin-2.63%
Net Profit Margin-2.14%
EBITDA Margin1.04%
EBIT Margin-3.88%
Analyst Forecast
The average price target for Bioqual is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-13.57%
EPS Growth Forecast41.93%